Geisinger Implements Exo Works™, POCUS Workflow Software by Exo®, to Enhance Patient Care

Geisinger is the first health system in PA to implement easy-to-use ultrasound workflow solution to expand the use of medical imaging across the health system at the point of care.

DANVILLE, Pa. and SANTA CLARA, Calif., Sept. 14, 2023 /PRNewswire/ -- Geisinger has implemented Exo Works™, a point-of-care ultrasound (POCUS) workflow software from Exo (pronounced "echo"), a medical imaging software and devices company, to simplify and streamline ultrasound exam documentation, billing, and quality assurance at the point of care to improve patient outcomes. 

"We are excited to collaborate with Exo, who shares Geisinger's vision of making the patient experience more efficient, attentive, and accurate—all qualities that make up the foundation to make better health easier," said Aalpen A. Patel, M.D., Department Chair of Radiology at Geisinger. "Geisinger has long been committed to accelerating healthcare innovation regionally and beyond. We're proud to be the first facility in Pennsylvania to implement Exo Works."

Exo Works addresses decades-long healthcare infrastructure challenges with post-exam documentation by integrating disparate process steps into one platform. Its secure, cloud-based solution can be accessed from a phone, tablet, or web browser, enabling physicians to do their work from anywhere.

Geisinger has implemented Exo Works in their Emergency, Women's Health, and Sports Medicine departments, and plans to expand to 14 other health departments soon. Having Exo Works seamlessly integrated with Geisinger's electronic health record (EHR) and picture archiving and communication system (PACS) systems means that ultrasound images will now appear in patient records, giving the clinicians who meet with patients downstream the ability to visually reference prior ultrasound procedures and examinations, rather than simply relying on notes.

"Exo has made a tremendous impact and is one of the few companies out there that approach POCUS workflow challenges from a system-wide, enterprise perspective rather than a siloed approach," said Aalpen A. Patel, M.D. "Exo addresses inefficiency challenges by blending intuitive design, security, and documentation best practices into one. Exo Works is great for improving patient care but also for our clinicians, so that makes it a win-win."

Exo Works comprises just one component of Exo's growing medical imaging ecosystem, which emphasizes a holistic approach to expanding ultrasound use at the point of care. The company acquired Medo AI, a medical artificial intelligence (AI) company, in 2022 and is preparing to release its category-redefining handheld device in the near future.

"It is so important to bolster talented caregivers at the point of care with powerful software that accelerates and enhances the patient experience. We've designed Exo Works to do just this," said Sandeep Akkaraju, Co-founder and CEO of Exo. "With Geisinger's deep medical expertise and numerous care facilities, we are excited to bring the future of medical imaging to Pennsylvania and beyond."

To learn more about Exo, visit exo.inc. 

About Geisinger
Geisinger is committed to making better health easier for the more than 1 million people it serves. Founded more than 100 years ago by Abigail Geisinger, the system now includes 10 hospital campuses, a health plan with more than half a million members, a research institute and the Geisinger College of Health Sciences, which includes schools of medicine, nursing and graduate education. With more than 25,000 employees and 1,700+ employed physicians, Geisinger boosts its hometown economies in Pennsylvania by billions of dollars annually. Learn more at geisinger.org or connect with us on Facebook, Instagram, LinkedIn, and Twitter.

About Exo
Exo is a medical imaging software and devices company. Exo believes everyone around the world should have access to high-quality, affordable and easy-to-use medical imaging. The company is on a mission to modernize medical imaging through its high-performance ultrasound platform and artificial intelligence. Exo's goal is to enable healthcare professionals to make critical, real-time decisions that ultimately improve patient outcomes. For more information, please visit exo.inc. Follow us at @exoeffect on Twitter, LinkedIn, Facebook and Instagram.

This press release contains forward-looking statements regarding Exo's future expectations, plans and prospects and are based on Exo's current expectations and speak only as of the date hereof. Exo disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise.

GEISINGER CONTACT: Natalie Buyny
nbuyny1@geisinger.edu

EXO CONTACT: Hannah Fairbanks
hfairbanks@v2comms.com

SOURCE Geisinger